| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/08/2008 | US7354993 Insecticidal polypeptides and methods of use thereof |
| 04/08/2008 | US7354909 Incubating dendritic precursor cells such as monocytes and plasmacytoid dendritic cells with immunostimulatory oligonucleotide to generate antigen presenting cells for use in treatment of cell proliferative disorders; immunotherapy |
| 04/08/2008 | US7354902 Comprises nucleotide sequence coding genetically engineered transferrin for use in cosmetic and cancer diagnostics; antiinflammatory agents; viricides; bactericides |
| 04/08/2008 | US7354894 Administering epidermal growth factor receptor antagonist; blocking with monoclonal antibody, a kinase inhibitor, a metalloproteinase inhibitor; treating nasal polyps, chronic obstructive pulmonary disease |
| 04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
| 04/08/2008 | US7354764 forming calcium phosphate into porous support structure of particlular size and shape, encapsulating and promoting cell growth; implantable tissue construct used in prosthesis |
| 04/08/2008 | US7354763 For use in tissue engineering; medical diagnosis; culture of human progenitor cells; isolation |
| 04/08/2008 | US7354762 Transfecting with an expression vector containing DNA construct encoding chimeric receptor; electroporation; use in immunotherapy and treatment of neuroblastoma |
| 04/08/2008 | US7354761 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance |
| 04/08/2008 | US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening |
| 04/08/2008 | US7354741 transferring N-acetylgalactosamine and N-acetylglucosamine using soluble protein; DNA can be used as probe for hybridization |
| 04/08/2008 | US7354739 Modulation contraction of stomach tissue; gastrointestinal disorders; applying peptide |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354729 Appararatus for use in the evaluation of cell prolifereative patterns |
| 04/08/2008 | US7354728 Coactivation of nuclear receptors |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354709 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/08/2008 | US7354703 Securin is required for chromosomal stability in human cells |
| 04/08/2008 | US7354702 Forming, preservation modelable biopolymer; harvesting tissue, deactivation of infections, applying pressure to tissue; tissue engineering |
| 04/08/2008 | US7354594 Merozoite surface protein 1 lacking glycosylation sites |
| 04/08/2008 | US7354585 Methods of treating coagulapathic or thrombotic disorders |
| 04/08/2008 | US7354583 Antibody-induced apoptosis |
| 04/08/2008 | US7354390 Probes derived from the cDNA or genomic DNA used to detect polymorphisms that distinguish EpEp and epep genotypes; control expression of genes encoding herbicide resistance, biological control of insects or pathogens, viral coat proteins to protect against viral infections |
| 04/08/2008 | CA2448318C Compositions and methods of increasing stress tolerance in plants |
| 04/08/2008 | CA2256369C A process for encapsulating viable animal cells |
| 04/08/2008 | CA2253838C Dp and e2f protein nuclear localisation signals and their use |
| 04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
| 04/08/2008 | CA2130454C Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| 04/08/2008 | CA2124967C Transgenic non-human animals capable of producing heterologous antibodies |
| 04/08/2008 | CA2111006C A novel receptor-type tyrosine kinase and use thereof |
| 04/03/2008 | WO2008040027A2 Directed differentiation and maturation of stem cell-derived cardiomyocytes |
| 04/03/2008 | WO2008038630A1 Method for high-level production of protein by utilizing atf4 and/or gadd34 |
| 04/03/2008 | WO2008038587A1 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 04/03/2008 | WO2008038579A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 04/03/2008 | WO2008038572A1 Composition for regeneration of periodontal hard tissue and method for regeneration of periodontal hard tissue |
| 04/03/2008 | WO2008038148A2 Stem cells and methods of making and using stem cells |
| 04/03/2008 | WO2008038138A1 Optimal method for recombinant production of a marine metalloprotein and uses thereof |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2008019379A3 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 04/03/2008 | WO2008019290A3 Human antibodies to erbb 2 |
| 04/03/2008 | WO2008008114A3 Use of adipose-derived stem cells for treatment of leukodystrophies |
| 04/03/2008 | WO2008002662A3 Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells |
| 04/03/2008 | WO2007146432A3 Processing procedure for peripheral blood stem cells |
| 04/03/2008 | WO2007144046A3 Agent for the treatment of malignant diseases |
| 04/03/2008 | WO2007137679A3 Device and substance for isolating mesenchymal stem cells (msc) |
| 04/03/2008 | WO2007130191A3 Isolaton and therapeutic application of adult retinal stem cells collected from extra-retinal tissues |
| 04/03/2008 | WO2007106559A3 An in vitro mucosal tissue equivalent |
| 04/03/2008 | WO2007095201A3 Pseudotyped retroviral vectors and methods of use thereof |
| 04/03/2008 | WO2007067683A3 Methods and compositions for expanding t regulatory cells |
| 04/03/2008 | WO2007028165A8 Stress tolerance in plants |
| 04/03/2008 | WO2006083971A3 Dr5 antibodies and uses thereof |
| 04/03/2008 | US20080083044 Cos for mechanical harvest |
| 04/03/2008 | US20080083043 Maize Cellulose Synthases and Uses Thereof |
| 04/03/2008 | US20080081841 Materials and Methods for Modulating Cell Motility |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
| 04/03/2008 | US20080081786 Cytokine protein family |
| 04/03/2008 | US20080081780 Identification of oligoadenylate synthetase-like genes |
| 04/03/2008 | US20080081373 Genetic inhibition by double-stranded RNA |
| 04/03/2008 | US20080081371 Low Density Spreading Methods For Somatic Embryogenesis |
| 04/03/2008 | US20080081370 Directed differentiation of human embryonic stem cells into mesenchymal/stromal cells |
| 04/03/2008 | US20080081369 Method for Chondrocyte Expansion with Phenotype Retention |
| 04/03/2008 | US20080081368 Preparing organ tissues immobilized on microscopic slides for histochemical analysis/staining; diagnosing inflammatory, ulceration and cell proliferative disorders |
| 04/03/2008 | US20080081367 Preparing leukocyte concentrate via multiple filtrations; treatment and pevention of bone disorders |
| 04/03/2008 | US20080081356 Production of glycoproteins |
| 04/03/2008 | US20080081354 Devices, vectors and methods for inducible ischemia cardioprotection |
| 04/03/2008 | US20080081353 Production of recombinant human collagen |
| 04/03/2008 | US20080081350 In vitro-differentiated retinal ganglion cells and method for producing same |
| 04/03/2008 | US20080081346 Using cell death inducing ligand as tool in treatment of cell proliferative disorders; immunotherapeutics; antitumor agents |
| 04/03/2008 | US20080081345 Sour taste receptor compositions and methods |
| 04/03/2008 | US20080081337 Using beta -cell specific insulin gene transcription factor (MafA) as diagnostic tool for identifying insulin producing cells |
| 04/03/2008 | US20080081323 Tissue growth apparatus for cell propagation; organ replacement and regenerative medicine |
| 04/03/2008 | US20080081044 Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | US20080081039 Inorganic Selenium For Treatment Of Cancer |
| 04/03/2008 | US20080081037 Methods and Agents for Diagnosis and Prevention, Amelioration or Treatment of Goblet Cell-Related Disorders |
| 04/03/2008 | US20080081033 Preparation of a cell concentrate from a physiological solution |
| 04/03/2008 | DE102006045550A1 Verfahren zur Herstellung von agglutionationsfähigen Thrombozytenfragmenten und deren Verwendung A process for preparing agglutionationsfähigen platelet fragments, and their use |
| 04/03/2008 | CA2700579A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2700436A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2664921A1 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 04/03/2008 | CA2663026A1 Apoptotic cell-mediated transfection of mammalian cells with interfering rna |
| 04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905824A1 A transgenic cell and a method for cell analysis |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905459A1 Method of producing tooth and method of producing teeth and tissue |
| 04/02/2008 | EP1904851A2 Method for evaluating cell populations |
| 04/02/2008 | EP1904844A2 Compositions and methods for enhancing axon regeneration |
| 04/02/2008 | EP1904625A2 Microscale micropatterned engineered in vitro tissue |
| 04/02/2008 | EP1904624A1 Method for culturingand proliferating hematopoietic stem cells and progenitor cells using human endometrial cells |
| 04/02/2008 | EP1904623A1 Therapeutic reprogramming of germ line stem cells |
| 04/02/2008 | EP1904622A2 Constitutive promoters from poplar and uses thereof |
| 04/02/2008 | EP1904621A2 Gene therapy methods and cell growth and cell transplant devices for use therein |
| 04/02/2008 | EP1904073A2 Inflammation |
| 04/02/2008 | EP1751661A4 Method for selectively expanding, selecting and enriching stem/progenitor cell populations |
| 04/02/2008 | EP1699288A4 Method of ex vitro sowing, germination, growth and conversion of plant somatic embryos or germinants, and nutrient medium used therefor |